Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Shares Issued (2016 - 2025)

Collegium Pharmaceutical has reported Shares Issued over the past 10 years, most recently at $985000.0 for Q4 2025.

  • Quarterly results put Shares Issued at $985000.0 for Q4 2025, up 110.65% from a year ago — trailing twelve months through Dec 2025 was $4.3 million (up 417.53% YoY), and the annual figure for FY2025 was $4.3 million, up 417.53%.
  • Shares Issued for Q4 2025 was $985000.0 at Collegium Pharmaceutical, down from $2.8 million in the prior quarter.
  • Over the last five years, Shares Issued for COLL hit a ceiling of $9.6 million in Q2 2024 and a floor of -$9.2 million in Q4 2024.
  • Median Shares Issued over the past 5 years was $1.3 million (2022), compared with a mean of $1.4 million.
  • Biggest five-year swings in Shares Issued: plummeted 213.02% in 2024 and later skyrocketed 1771.81% in 2025.
  • Collegium Pharmaceutical's Shares Issued stood at $2.3 million in 2021, then crashed by 291.06% to -$4.5 million in 2022, then skyrocketed by 283.06% to $8.2 million in 2023, then plummeted by 213.02% to -$9.2 million in 2024, then surged by 110.65% to $985000.0 in 2025.
  • The last three reported values for Shares Issued were $985000.0 (Q4 2025), $2.8 million (Q3 2025), and -$1.0 million (Q2 2025) per Business Quant data.